GPCRact:通过全沟通建模预测连接体诱导的GPCR活动的层次框架
1Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea.
Briefings in bioinformatics
|January 15, 2026
概括
GPCRact通过使用新型图形神经网络框架模拟全沟通来准确预测G蛋白结合受体活性,从而改善药物发现. 这种方法捕捉复杂的3D动态,以更好地进行结构导向设计.
科学领域:
- 计算化学和结构生物学
- 药理学和药物发现
- 在生物信息学中的机器学习.
背景情况:
- 预测G蛋白结合受体 (GPCR) 在联体结合时的活性对于药物发现至关重要.
- 建模体通信,GPCRs中的远程信号,仍然是当前基于序列的模型的一个重大挑战.
- 现有的模型往往无法捕捉到GPCR激活的复杂的三维动态,特别是对于质复杂的标.
研究的目的:
- 介绍GPCRact,一个新的计算框架,旨在模拟GPCR激活中全调节的生物物理原理.
- 开发一种方法,通过明确考虑三维结构动态和全路径,准确预测连接体诱导的GPCR活性.
- 为以结构为导向的药物发现提供一个更易于解释和机械基础的工具,针对GPCRs.
主要方法:
- 构建一个高分辨率的3D结构感知图表,表示GPCR中的功能关键残留物.
- 实现双重注意体系结构,包括对联体蛋白相互作用的交叉注意力和信号传播的自我注意力,建立在一个E (n) -Equivariant Graph神经网络 (EGNN) 上.
- 开发一个量身定制的损失函数和推理逻辑,以减轻错误的传播,并明确模拟构造变化.
主要成果:
- 在预测GPCR活性方面,GPCRact实现了最先进的性能.
- 该框架在表复杂受体的基准测试上表现出卓越的准确性,而传统模型表现不佳.
- 对学习注意力权重的分析验证了生物相关的全性通路的识别,提高了模型的解释性.
结论:
- GPCRact通过有效建模全沟通,在准确预测带诱导的GPCR活性方面取得了重大进展.
- 与以前的方法相比,该框架提供了一种更易于解释和基于机制的方法,解决了GPCR调制的"黑子"性质.
- 通过提供一个强大的工具来理解GPCR激活动态,GPCRact为更有效的结构导向药物发现铺平了道路.
相关概念视频
The Two-State Receptor Model
3.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.0K
GPCRs Regulate Adenylyl Cylase Activity
7.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.3K
G Protein-coupled Receptors
16.5K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.5K
Assembly of Signaling Complexes
6.5K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
6.5K
Transducer Mechanism: G Protein–Coupled Receptors
4.0K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
4.0K
Cooperative Allosteric Transitions
8.6K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.6K


